Prelude Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,464
Closed -$262K 1213
2025
Q1
$262K Sell
34,464
-196,179
-85% -$1.64M 0.02% 769
2024
Q4
$2.22M Sell
230,643
-166,281
-42% -$1.3M 0.14% 164
2024
Q3
$2.35M Sell
396,924
-24,487
-6% -$162K 0.14% 188
2024
Q2
$2.92M Buy
421,411
+110,440
+36% +$777K 0.2% 128
2024
Q1
$2.39M Buy
310,971
+16,237
+6% +$131K 0.13% 200
2023
Q4
$2.58M Sell
294,734
-67,932
-19% -$497K 0.17% 133
2023
Q3
$2.64M Buy
+362,666
New +$2.7M 0.17% 137
2023
Q2
Sell
-12,411
Closed -$42.3K 1267
2023
Q1
$42.3K Buy
+12,411
New +$48.1K ﹤0.01% 1012
2021
Q2
Sell
-14,102
Closed -$145K 1835
2021
Q1
$145K Buy
14,102
+755
+6% +$7.3K ﹤0.01% 1381
2020
Q4
$121K Buy
+13,347
New +$96.1K ﹤0.01% 1172
2016
Q2
Sell
-12,500
Closed -$109K 1666
2016
Q1
$109K Buy
+12,500
New +$104K 0.02% 734
2015
Q4
Sell
-5,240
Closed -$51K 1590
2015
Q3
$51K Sell
5,240
-25,730
-83% -$272K 0.01% 1054
2015
Q2
$359K Buy
30,970
+13,470
+77% +$139K 0.05% 395
2015
Q1
$182K Buy
17,500
+14,000
+400% +$131K 0.03% 698
2014
Q4
$40K Buy
+3,500
New +$34.6K 0.01% 1368

Other funds holding MDXG

Prelude Capital Management's MDXG Position: Q2 2025 in Review

Prelude Capital Management sold out of MiMedx Group (MDXG) in Q2 2025, closing a stake of 34,464 shares — an estimated $262K sold.

Prelude Capital Management first reported a position in MDXG in Q4 2014 and held it in 15 quarters. The position peaked at $2.92M in Q2 2024. 223 funds tracked by Wall St. Rank hold MDXG as of Q2 2025.

  • Prelude Capital Management reported no remaining MiMedx Group position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 34,464 MiMedx Group shares in Q2 2025, an estimated $262K.
  • Prelude Capital Management first reported a position in MiMedx Group in Q4 2014 and held it in 15 quarters.
  • Prelude Capital Management's MiMedx Group position peaked at $2.92M in Q2 2024.
  • 223 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.